• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Transcode Therapeutics Inc (NQ: RNAZ )

    1.010 -0.120 (-10.62%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 398,000
    Open 1.130
    Bid (Size) 1.020 (4)
    Ask (Size) 1.100 (4)
    Prev. Close 1.130
    Today's Range 1.000 - 1.140
    52wk Range 0.1212 - 4.530
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga

    Performance

    YTD
    +525.77%
    +525.77%
    1 Month
    -15.13%
    -15.13%
    3 Month
    +44.29%
    +44.29%
    6 Month
    +552.03%
    +552.03%
    1 Year
    -61.74%
    -61.74%

    More News

    Read More
    Nasdaq Determines That TransCode Therapeutics Has Regained Compliance with Continued Listing Requirements
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    RNAZ Stock Earnings: TransCode Therapeutics Misses EPS for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    TransCode Therapeutics Reports Positive Data from First-in-Human Clinical Study Using Novel Lead Therapeutic Candidate, TTX-MC138
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Why TransCode Therapeutics (RNAZ) Stock Is Getting Hammered
    Via Benzinga
    Squarespace (SQSP) Stock Climbs 13% on $6.9 Billion Deal to Go Private
    Via InvestorPlace
    Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?
    Via InvestorPlace
    TransCode Therapeutics Open Letter to Shareholders
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    Via InvestorPlace
    TransCode Therapeutics Announces FDA Clearance To Initiate Phase 1/2 Clinical Trial with TTX-MC138 in Patients with Advanced Solid Tumors
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    TransCode Therapeutics Reports 2023 Results; Provides Business Update
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    TransCode Therapeutics Announces Appointment of Daniel Vlock, M.D., as Chief Medical Officer
    From TransCode Therapeutics, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.